The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization-Reference-Cited by-同舟云学术

The Combination Vaccine Adjuvant System Alum/c-di-AMP Results in Quantitative and Qualitative Enhanced Immune Responses Post Immunization

Published:2019-02-19 Issue: Volume:9 Page:
ISSN:2235-2988
Container-title:Frontiers in Cellular and Infection Microbiology
language:
Short-container-title:Front. Cell. Infect. Microbiol.

Author:

Ebensen Thomas,Delandre Simon,Prochnow Blair,Guzmán Carlos A.,Schulze Kai

Publisher

Frontiers Media SA

Subject

Infectious Diseases,Microbiology (medical),Immunology,Microbiology

Reference43 articles.

1. Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus;Bagnoli;Proc. Natl. Acad. Sci. U.S.A.,2015

2. Efficacy and safety of immunological adjuvants. Where is the cut-off?;Batista-Duharte;Biomed. Pharmacother.,2018

3. Aluminium hydroxide adjuvant initiates strong antigen-specific Th2 responses in the absence of IL-4- or IL-13-mediated signaling;Brewer;J. Immunol.,1999

4. STING is a direct innate immune sensor of cyclic di-GMP;Burdette;Nature,2011

5. Vaccination strategies to promote mucosal antibody responses;Chen;Immunity,2010

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Addition of nucleotide adjuvants enhances the immunogenicity of a recombinant subunit vaccine against the Zika virus in BALB/c mice;Vaccine;2024-11

2. The role of cyclic nucleotides in bacterial antimicrobial resistance and tolerance;Trends in Microbiology;2024-09

3. The adjuvant BcfA activates antigen presenting cells through TLR4 and supports TFH and TH1 while attenuating TH2 gene programming;Frontiers in Immunology;2024-08-29

4. Wuhan Sequence-Based Recombinant Antigens Expressed in E. coli Elicit Antibodies Capable of Binding with Omicron S-Protein;International Journal of Molecular Sciences;2024-08-20

5. Current status and future directions for the development of human papillomavirus vaccines;Frontiers in Immunology;2024-06-25